oxazoles has been researched along with Liver Dysfunction in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcorn, HW; Fang, E; Flanagan, S; Marbury, TC; Minassian, SL; Morris, D; Ponnuraj, R; Prokocimer, P | 1 |
| Okamoto, T; Park, CH; Toriizuka, K; Yamabe, N; Yokozawa, T | 1 |
| Harvison, PJ; Kennedy, EL; Tchao, R | 1 |
| Dixon, R; Warrander, A | 1 |
| Delvaux, M; Dixon, R; French, S; Kemp, J; Leclerc, V; Rautureau, J; Sellers, M | 1 |
| Ishikawa, A; Misawa, S; Okamura, T; Ono, A; Tanaka, E | 1 |
| Ehrhardt, JD; Genissel, P; Pozet, N; Singlas, E; Zech, P | 1 |
| Ardalan, B; Belt, RJ; Benjamin, RS; McGovren, JP; Ohnuma, T; Pratt, EA; Taylor, SA | 1 |
3 trial(s) available for oxazoles and Liver Dysfunction
| Article | Year |
|---|---|
Pharmacokinetics of tedizolid in subjects with renal or hepatic impairment.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; Cross-Over Studies; Female; Humans; Kidney; Kidney Failure, Chronic; Liver; Liver Diseases; Male; Middle Aged; Organophosphates; Oxazoles; Oxazolidinones; Prodrugs; Renal Dialysis; Tetrazoles; Young Adult | 2014 |
Effect of hepatic impairment on the pharmacokinetics of zolmitriptan.
Topics: Adult; Aged; Area Under Curve; Biotransformation; Blood Pressure; Female; Half-Life; Humans; Liver Diseases; Male; Middle Aged; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Tryptamines | 1998 |
Pharmacokinetic and biochemical studies on acivicin in phase I clinical trials.
Topics: Antibiotics, Antineoplastic; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Clinical Trials as Topic; Drug Evaluation; Female; Humans; Isoxazoles; Kinetics; Liver Diseases; Male; Oxazoles | 1985 |
5 other study(ies) available for oxazoles and Liver Dysfunction
| Article | Year |
|---|---|
Chinese prescription kangen-karyu ameliorates the development of diabetic hepatic damages via regulating oxidative stress and inflammation in the liver of db/db mice.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Cyclooxygenase Inhibitors; Diabetes Complications; Drugs, Chinese Herbal; Glucose; Hyperglycemia; Inflammation; Inflammation Mediators; Liver; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidase 4; NADPH Oxidases; NF-kappa B; Nitric Oxide Synthase Type II; Oxazoles; Oxidative Stress; Phytotherapy | 2011 |
Nephrotoxic and hepatotoxic potential of imidazolidinedione-, oxazolidinedione- and thiazolidinedione-containing analogues of N-(3,5-dichlorophenyl)succinimide (NDPS) in Fischer 344 rats.
Topics: Alanine Transaminase; Animals; Blood Glucose; Blood Urea Nitrogen; Chemical and Drug Induced Liver Injury; Fungicides, Industrial; Imidazoles; Kidney Diseases; Liver Diseases; Male; Oxazoles; Proteinuria; Rats; Rats, Inbred F344; Succinimides; Thiazoles | 2003 |
The clinical pharmacokinetics of zolmitriptan.
Topics: Absorption; Adult; Case-Control Studies; Female; Humans; Liver Diseases; Male; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Tissue Distribution; Tryptamines | 1997 |
Trimethadione metabolism in patients with normal liver and in patients with chronic liver disease.
Topics: Carcinoma, Hepatocellular; Chronic Disease; Dimethadione; Female; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Oxazoles; Trimethadione | 1987 |
Pharmacokinetics of rilmenidine.
Topics: Absorption; Administration, Oral; Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Female; Humans; Hypertension; Kidney Failure, Chronic; Liver Diseases; Male; Middle Aged; Oxazoles; Rilmenidine | 1988 |